Cargando…
Gut microbiome and checkpoint inhibitor colitis
Immune checkpoint inhibitor therapies such as ipilimumab, are increasingly being used as a treatment option for a variety of cancers, including metastatic melanoma and have demonstrated effectively a prolonged survival. These agents have an immunological mode of action that predisposes patients to a...
Autores principales: | Sehgal, Kanika, Khanna, Sahil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566823/ https://www.ncbi.nlm.nih.gov/pubmed/33249800 http://dx.doi.org/10.5217/ir.2020.00116 |
Ejemplares similares
-
Gut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface
por: Sehgal, Kanika, et al.
Publicado: (2021) -
Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review
por: Hwang, Sung Wook, et al.
Publicado: (2023) -
Gut microbiome in modulating immune checkpoint inhibitors
por: Li, Xiang, et al.
Publicado: (2022) -
The natural history of histological changes in microscopic
colitis
por: Sehgal, Kanika, et al.
Publicado: (2023) -
Gut microbiome modulates efficacy of immune checkpoint inhibitors
por: Yi, Ming, et al.
Publicado: (2018)